UNSPSC 51282501: Cefacetrile or cephacetrile

This classification denotes an anti-bacterial agent with the molecular formula C13H13N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FDM21QQ344, chemically known as (6r,7r)-3-acetoxymethyl-7-(2-cyanacetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure but generally known as cefacetrile, which bears US NIH Compound Identifier 91562. Cefacetrile most often comes in base and sodium forms.

UNSPSC 51282501 Cefacetrile or cephacetrile is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The code does not match the work actually being purchased under it in recent solicitations: the Illinois Department of Public Health's August 2026 piggyback pharmaceutical contract awarded to Chartwell Rx LLC covered Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets (antibiotics outside the cephalosporin family), and Seminole County, Florida's June 2026 IFB solicitation (IFB60459723LAS) sought Naloxone and Safe Drug Deactivation Systems—neither of which are cefacetrile or cephacetrile compounds. The pharmaceutical warehouse and emergency-response-drug purchasing activity visible under this code reflects state departments and county health agencies buying bulk pharmaceutical supplies and medical countermeasures through piggyback cooperative agreements and competitive bid processes, but the products being solicited do not align with the code's actual pharmaceutical scope.

The two recent opportunities come from Illinois (state department) and Florida (county). The Illinois contract, awarded to Chartwell Rx LLC for $2,999,999.11 over a 12-month initial term with two one-year renewal options, used an Invitation for Bid process through the MMCAP Infuse consortium with a September 11, 2026 response deadline. Seminole County's IFB for Naloxone and Safe Drug Deactivation Systems—1,900 units of Naloxone and 800 deactivation systems annually—called for quarterly deliveries to the county's Community Health Building in Sanford, Florida, with a July 26, 2023 response deadline and potential FEMA funding. The mismatch between the code's stated pharmaceutical scope and the antibiotics and emergency-response products actually being procured suggests either upstream classification error in the sourcing systems or that this code is not seeing active purchasing volume in cefacetrile or cephacetrile compounds at the state and local level.